Difference between revisions of "Talk:Bioblast 2022"
From Bioblast
Line 26: | Line 26: | ||
|- | |- | ||
|- | |- | ||
| '''11:30-12:15''' || '''Scientific Session II''' || || | | '''11:30-12:15''' || '''Scientific Session II''' || || '''Molecular, kinetic, and thermodynamic advances in bioenergetics''' || | ||
|- | |- | ||
|- | |- | ||
| || | | || || 11:30-11:45|| || [[Komlodi Timea]] | ||
|- | |- | ||
|- | |- | ||
| || | | || || 11:45-12:00 || || | ||
|- | |- | ||
|- | |- | ||
| || | | || || 12:00-12:15 ||[[Chicco Adam J |Resolving the Rotenone Paradox: elucidating the Complexity of multi-substrate respirometry protocols]] || [[Chicco Adam J]] | ||
|- | |- | ||
|- | |- | ||
Line 41: | Line 41: | ||
|- | |- | ||
|- | |- | ||
| || | | || || 12:15-12:20 || || | ||
|- | |- | ||
|- | |- | ||
| || | | || || 12:20-12:25 || || | ||
|- | |- | ||
|- | |- | ||
| || | | || || 12:20-12:30 || | | ||
|- | |- | ||
|- | |- | ||
Line 53: | Line 53: | ||
|- | |- | ||
|- | |- | ||
| '''14:00-15:00''' ||'''Scientific Session III''' || || | | '''14:00-15:00''' ||'''Scientific Session III''' || || Perspectives of bioenergetics in health and disease || | ||
|- | |- | ||
|- | |- | ||
| || | | || || 14:00 - 14:15|| || | ||
|- | |- | ||
|- | |- | ||
| || | | || || 14:15 - 14:30 || [[MX Mexiko City Moreno-Sanchez R |Estimation of energy pathway fluxes in cancer cells- beyond the Warburg effect]] || [[MX Mexiko City Moreno-Sanchez R]] | ||
|- | |- | ||
|- | |- | ||
| || | | || || 14:30 - 14:45 || || | ||
|- | |- | ||
|- | |- | ||
| || | | || || 14:45 - 15:00 || ::::## [[Neuzil Jiri|Metabolic switch utilizing ammonia supports proliferation in regenerating liver]] || [[Neuzil Jiri]] | ||
|- | |- | ||
|- | |- | ||
Line 92: | Line 92: | ||
|- | |- | ||
|- | |- | ||
| '''16:00-17:15''' ||'''Scientific Session IV''' || || || | | '''16:00-17:15''' ||'''Scientific Session IV''' || || Perspectives of bioenergetics in health and disease II || | ||
|- | |- | ||
|- | |- | ||
| || | | || || 16:00 - 16:15|| [[Stiban Johnny|NUBPL: a mitochondrial Complex I deficiency disorder]] || [[Stiban Johnny]] | ||
|- | |- | ||
|- | |- | ||
| || | | || || 16:15 - 16:30 || [[Chakrabarti Sasanka |Rotenone cytotoxicity on SH-SY5Y cells: role of ferroptosis, mitochondria and alpha-synuclein]] || [[Chakrabarti Sasanka]] | ||
|- | |- | ||
|- | |- | ||
| || | | || || 16:30 - 16:35 || || | ||
|- | |- | ||
|- | |- | ||
| || | | || || 16:35 - 16:40 || || | ||
|- | |- | ||
|- | |- | ||
| || | | || || 16:40 - 16:45 || || | ||
|- | |- | ||
|- | |- | ||
| || | | || || 16:45 - 17:00 || || | ||
|- | |- | ||
|- | |- | ||
| || | | || || 17:00 - 17:15 || [[Karabatsiakis Alexander |Effects of eye-movement desensitization and reprocessing (EMDR) therapy on mitochondrial bioenergetics in immune cells from patients with post-traumatic stress disorder (PTSD): a pilot study]] || [[Karabatsiakis Alexander]] | ||
|- | |- | ||
|- | |- | ||
Line 123: | Line 123: | ||
! Time (CET) !!Type of speech !! Time per lecture !!Title !! Speaker | ! Time (CET) !!Type of speech !! Time per lecture !!Title !! Speaker | ||
|- | |- | ||
| '''09:15 - 10:35''' || '''Scientific Session V''' || || | | '''09:15 - 10:35''' || '''Scientific Session V''' || || Mitochondrial pharmacology || | ||
|- | |- | ||
|- | |- | ||
| || | | || || 09:15 - 09:30 || [[Koopman_Werner_JH |The decylTPP mitochondria-targeting moiety lowers electron transport chain supercomplex levels in primary human skin fibroblasts]] || [[Koopman_Werner_JH]] | ||
|- | |- | ||
|- | |- | ||
| || | | || || 09:30 - 09:45 || [https://abliva.com/company/ Towards a treatment for mitochondrial disease: Current compounds in clinical development] || | ||
|- | |- | ||
|- | |- | ||
| || | | || || 09:45 - 10:00 || || [[Dambrova Maija]] | ||
|- | |- | ||
|- | |- | ||
| || | | || || 10:00 - 10:20 || [[MitoKIN |Kinase perturbations redirect mitochondrial function]] || [[Torres-Quesada Omar]] | ||
|- | |- | ||
|- | |- | ||
| || | | || || || || [[Eduard Stefan]] | ||
|- | |- | ||
|- | |- | ||
| || | | || || 10:20 - 10:35 || [[Chicco Adam J |Resolving the Rotenone Paradox: elucidating the Complexity of multi-substrate respirometry protocols]]|| [[Chicco Adam J]] | ||
|- | |- | ||
|- | |- | ||
Line 150: | Line 150: | ||
|- | |- | ||
|- | |- | ||
| '''11:30 - 12:30''' || '''Scientific Session VI''' || || || | | '''11:30 - 12:30''' || '''Scientific Session VI''' || || Methodological advancements in bioenergetics || | ||
|- | |- | ||
|- | |- | ||
| || | | || || 11:30 - 11:45 || [[Ecker Rupert|Contextual Tissue Cytometry with AI – Functional Single Cell Analyses ''in-situ'']] || [[Ecker Rupert]] | ||
|- | |- | ||
|- | |- | ||
| || | | || || 11:45 - 12:00 || [https://www.incyton.com/ Physiometabolic RTCA on an automated platform for short and long term applications] || [[Wolf Peter]] | ||
|- | |- | ||
|- | |- | ||
| || | | || || 12:00 - 12:15 || || | ||
|- | |- | ||
|- | |- | ||
| || | | || || 12:15 - 12:30 || || | ||
|- | |- | ||
|- | |- | ||
Line 168: | Line 168: | ||
|- | |- | ||
|- | |- | ||
| '''14:00-15:30''' ||'''Scientific Session VII''' || || | | '''14:00-15:30''' ||'''Scientific Session VII''' || || Methodological advancements in bioenergetics II || | ||
|- | |- | ||
|- | |- | ||
| || | | || || 14:00 - 14:15|| [[Cardoso 2022 Abstract Bioblast |Redox monitoring and respiration - a new horizon with the NextGen-O2k]] || [[Cardoso Luiza HD]] | ||
|- | |- | ||
|- | |- | ||
| || | | || || 14:15 - 14:30 || [[Garcia-Roves Pablo Miguel |Tuning the assessment of coenzyme Q redox state and respiration in skeletal muscle permeabilized fibers]] || [[Garcia-Roves Pablo Miguel]] | ||
|- | |- | ||
|- | |- | ||
| || | | || || 14:30 - 14:45 || [[Cecatto Cristiane|Mitochondrial calcium uptake capacity is lower than calcium retention capacity in the presence and absence of cyclosporin A]] || [[Cecatto Cristiane]] | ||
|- | |- | ||
|- | |- | ||
| || | | || || 14:45 - 15:00 || Oxia || [[Schmitt Sabine]] | ||
|- | |- | ||
|- | |- | ||
| || | | || || 15:00 - 15:15 || || | ||
|- | |- | ||
|- | |- | ||
| || | | || || 15:15 - 15:30 || || | ||
|- | |- | ||
|- | |- |
Revision as of 18:27, 17 May 2022
Program
2022-06-29 Day 1 of scientific presentations
2022-06-30 Day 2 of scientific presentations